Citi Pharma Limited (PSX:CPHL)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
89.70
+3.27 (3.78%)
At close: Dec 5, 2025
78.26%
Market Cap 20.49B
Revenue (ttm) 13.30B
Net Income (ttm) 894.23M
Shares Out 228.46M
EPS (ttm) 3.91
PE Ratio 22.94
Forward PE 14.24
Dividend 3.50 (3.90%)
Ex-Dividend Date Oct 17, 2025
Volume 6,459,147
Average Volume 1,866,546
Open 87.51
Previous Close 86.43
Day's Range 86.00 - 90.49
52-Week Range 49.02 - 109.30
Beta 0.49
RSI 63.87
Earnings Date Feb 26, 2026

About Citi Pharma

Citi Pharma Limited engages in the manufacture and sale of pharmaceutical, medical chemical, and botanical products in Pakistan. Its product portfolio includes capsules, tablet, syrup drops, ointment, sachet, and formulation. Citi Pharma Limited was incorporated in 2012 and is headquartered in Lahore, Pakistan. [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 2012
Employees 531
Stock Exchange Pakistan Stock Exchange
Ticker Symbol CPHL
Full Company Profile

Financial Performance

In 2025, Citi Pharma's revenue was 13.15 billion, an increase of 6.00% compared to the previous year's 12.41 billion. Earnings were 892.04 million, an increase of 7.03%.

Financial Statements

News

There is no news available yet.